Auxein Medical made a significant impact at IASCON 2024, unveiling groundbreaking research on bioabsorbable screws and engaging with the arthroscopy community. This event marks a pivotal moment in Auxein’s commitment to advancing orthopaedic care through innovative technology.

Transforming Orthopaedic Surgery with Bioabsorbable Technology: At the heart of Auxein’s innovation are bioabsorbable implants designed to enhance healing while minimizing complications. These implants gradually dissolve within the body, supporting natural bone growth without the need for invasive removal surgeries. This is especially crucial for paediatric patients, allowing for normal bone development without restricting growth or necessitating future procedures.

Investment in Advanced Manufacturing: To ensure the highest quality of bioabsorbable screws, Auxein has invested in state-of-the-art machinery imported from Germany. Additionally, the company is expanding its manufacturing footprint from 3,150 square meters to approximately 4,050 square meters. This expansion will facilitate a wider range of orthopaedic and arthroscopy products, reinforcing Auxein’s position as a leader in the industry.

Auxein Medical’s commitment to enhancing patient outcomes begins with substantial investments in technology. Our dedication to R&D is reflected in our policy of reinvesting 12% of Auxein’s total revenue each year, ensuring we meet the evolving needs of patients and healthcare providers.

The Future of Patient Care: Bioabsorbable implants present numerous benefits:

• Gradual Dissolution: No need for invasive removal surgeries.
• Lower Complication Risks: Reduced likelihood of infections and implant loosening.
• Supports Natural Healing: Facilitates integration and recovery.
• Immediate Stabilization: Enhances comfort during the healing process.

Bioabsorbable implants are set to revolutionize orthopaedic surgery. They provide essential support for growing children, preventing the complications associated with fixed implants.

The orthopaedic implant market in India is projected to exceed $56.3 billion by 2031, reflecting a compound annual growth rate of 5.0%. The growing demand for bioabsorbable implants aligns with the need for sustainable healthcare solutions, with the bioabsorbable implant market expected to grow from $664.8 million in 2024 to $836.5 million by 2034.

About Auxein Medical: Auxein is committed to advancing medical technology through innovative orthopaedic and arthroscopy solutions, dedicated to improving patient outcomes globally. With operations in over 90 countries, Auxein has cared for over 20 million patients and offers a portfolio of 3,000+ products, including 200+ FDA-approved solutions.

For more information about Auxein, please visit https://www.auxein.com/